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ABSTRACT 8 
In this statement, the EFSA GMO Panel responds to a request from the European Commission (EC) to assess the 9 
safety of soybean MON 87705 oil for commercial frying. The applicant provided exposure assessments based on 10 
total and partial substitutions of conventional soybean, rapeseed and sunflower oils with the soybean MON 11 
87705 oil in foods (salad dressings, margarines and spreads, mayonnaise, crackers and salty snacks and 12 
soybean/rapeseed/sunflower oils processed foods). No distinction was made between commercial and domestic 13 
use, nor whether the oils were used in frying or not. The EFSA GMO Panel considers that this exposure scenario 14 
is the most pertinent in that it addresses not only the question raised by the EC about the possible use of soybean 15 
MON 87705 oil in frying, but also other possible food uses. Having assessed total replacement, the most 16 
conservative scenario arising from both domestic and commercial use of the oil, the EFSA GMO Panel 17 
concluded that the use of soybean MON 80775 oil does not impact on human health and nutrition. The Panel 18 
recommends a post-market monitoring plan for the marketed foods and feed. 19 
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SUMMARY 25 
The European Commission requested the EFSA GMO Panel, on 7 January 2013, to complement its 26 
opinion related to soybean MON 87705 by an assessment of the safety of using soybean MON 87705 27 
oil for commercial frying. To do so, EFSA requested data from the applicant. The applicant provided 28 
an exposure assessment based on three substitution levels to replace conventional soybean, rapeseeed 29 
and sunflower oils in foods categorised in the UK National Diet and Nutrition Survey of 2008–2010. 30 
Foods considered are salad dressings, margarines and spreads, mayonnaise, crackers and salty snacks 31 
and soybean/rapeseed/sunflower oils processed foods. No distinction was made between commercial 32 
and domestic use, nor whether the oils were used in frying or not. The average and upper percentile 33 
intakes (expressed as g/day and as E % of the total diet) of five fatty acids (palmitic, stearic, oleic, 34 
linoleic and α-linolenic acid) arising from a total substitution of other oils by soybean MON 87705 oil 35 
were estimated, and the likely changes in total fatty acid consumption from the whole diet were 36 
calculated. 37 
The EFSA GMO Panel considers that this exposure scenario is the most pertinent in that it addresses 38 
not only the question raised by the EC about the possible use of soybean MON 87705 oil in frying, but 39 
also other possible food uses. The total replacement constitutes the most conservative scenario arising 40 
from both commercial and non-commercial uses of the oil. The EFSA GMO Panel concluded that the 41 
use of soybean MON 80775 oil does not impact on human health and nutrition. The Panel 42 
recommends a post-market monitoring plan, focusing on the collection of consumption data for the 43 
European population, for the marketed foods and feed. 44 
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BACKGROUND  61 
Genetically modified soybean MON 87705 has an increased oleic acid content and exhibits tolerance 62 
to glyphosate-containing herbicides. The intended uses for soybean MON 87705 oil, as proposed by 63 
the applicant, are in margarine, salad dressing, mayonnaise and home-use liquid vegetable oil, 64 
excluding the use for commercial frying.
4
 On 30 October 2012 the EFSA GMO Panel published a 65 
Scientific Opinion on application EFSA-GMO-NL-2010-78 for the placing on the market of the 66 
soybean MON 87705 for food and feed uses, import and processing under Regulation (EC) No 67 
1829/2003 (EFSA GMO Panel, 2012). 68 
During the authorisation process, the EC noted that while the application is of full scope (for all food 69 
and feed uses, import and processing), the scientific opinion does not conclude on the safety of the oil 70 
for commercial frying. On 7 January 2013 the European Commission asked the EFSA GMO Panel to 71 
complement its opinion on soybean MON 87705 oil to include an assessment of the safety of the oil 72 
for commercial frying, and to request missing data from the applicant, if needed. 73 
On 3 April 2013 EFSA requested the applicant to provide an exposure assessment on EU consumers 74 
for the oil extracted from soybean MON 87705 when used for commercial frying and to include 75 
scenarios for mean and high consumers. On 22 May 2013 EFSA received the requested data. 76 
The EFSA GMO Panel evaluated these data, and expresses its view in this statement. According to 77 
Regulation (EC) No 1829/2003, this statement complements the scientific opinion, which is the report 78 
requested under Articles 6(6) and 18(6) of that Regulation, and will be part of the EFSA overall 79 
Opinion in accordance with Articles 6(5) and 18(5). 80 
TERMS OF REFERENCE 81 
The EFSA GMO Panel was requested, in accordance with Articles 6(6) and 18(6) of Regulation (EC) 82 
No 1829/2003, to complement its scientific opinion on soybean MON 87705 on the safety of oil for 83 
commercial frying. 84 
85 
                                                     
4 Quoted from Application EFSA-GMO-NL-2010-78/applicant response to EFSA questions of 11 November 2011 (received 
by EFSA on 29 December 2011) as “It needs to be repeated that MON 87705 soybean oil, similar to commodity soybean 
oil, has a polyunsaturated fatty acid (PUFA) content that is not optimal for commercial frying (i.e., high temperature and 
repeated frying); hence, MON 87705 soybean oil is not targeted for these applications.” 
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EVALUATION 86 
1. Introduction 87 
This request from the European Commission concerns a published scientific opinion for application 88 
EFSA-GMO-NL-2010-78 on soybean MON 87705 for food and feed uses, import and processing 89 
(EFSA GMO Panel, 2012). The GMO Panel stated in its scientific opinion that “The applicant did not 90 
provide data which would allow a nutritional assessment of soybean MON 87705 oil when used for 91 
commercial frying.” Commercial and domestic frying is not an application intended by the applicant 92 
for soybean MON 87705 oil. In the light of this request from the EC, EFSA asked the applicant for an 93 
exposure assessment based on the use of soybean MON 87705 oil for commercial frying. In this 94 
statement, the EFSA GMO Panel evaluates the additional data provided by the applicant. 95 
2. Exposure assessment addressing the soybean MON 87705 oil in all food uses including 96 
frying
5
 97 
2.1. Exposure scenarios  98 
Soybean, rapeseed and sunflower oils account for 80 % of vegetable oil consumed in the UK 99 
(FAOSTAT, 2012). In this assessment soybean MON 87705 oil is assumed to replace conventional 100 
soybean, rapeseed and sunflower oils in foods consumed by the UK population aged 19 years or older. 101 
Consumption data are taken from the UK National Diest and Nutrition Survey of 2008–2010 (Bates et 102 
al., 2011). These consumption data are more recent than those used in the initial submission and 103 
assessment of soybean MON 87705 oil (EFSA GMO Panel, 2012). Foods considered are: salad 104 
dressings, margarines and spreads, mayonnaise, crackers and salty snacks and 105 
soybean/rapeseed/sunflower oils processed foods. The content of soybean/rapeseed/sunflower oils in 106 
foods belonging to these categories of foods are calculated from available databanks (FSA, 2002). The 107 
Panel considers that this scenario is the most pertinent in that it addresses not only the question raised 108 
by the EC about the possible use of soybean MON 87705 oil in frying, but also other possible food 109 
uses. The EFSA GMO Panel considers this selection of food items conservative, because it covers the 110 
majority of foods made of or with vegetable oils, including both the commercial and the domestic use 111 
of oils, also for frying. 112 
The applicant provided an assessment based on three substitution levels of three vegetable oils with 113 
soybean MON 87705 oil. The EFSA GMO Panel selected the 100 % substitution as the most 114 
conservative scenario arising from both domestic and commercial use of the vegetable oils. The 115 
average and upper percentile intakes (expressed as g/day and as E % of the total diet) of fatty acid 116 
groups (SFAs [saturated fatty acids], MUFAs [monounsaturated fatty acids], n-3 PUFAs 117 
[polyunsaturated acids] and n-6 PUFAs) are calculated (see Table 1). 118 
Table 1:  Estimated daily intake (E %) of fatty acid groups before and after the replacement. 119 
Predicted changes in the total diet with respect to fatty acid groups (SFAs, MUFAs, PUFAs) are given 120 
as percentage of total energy in adults > 19 years old (average per capita and 97.5th percentile 121 
consumers) through replacement of all consumed vegetable oils (soybean, rapeseed, sunflower) by 122 
soybean MON 87705 oil 123 
Fatty 
acid 
group 
Males Females 
Average
(a)
 97.5th %
(b)
 Average
(a)
 97.5th %
(b)
 
Before After Before After Before After Before After 
SFA 12.4 9.9 19.7 15.2 12.5 10.0 19.4 15.3 
MUFA 11.9 18.3 17.3 26.6 11.6 17.6 17.0 25.9 
n-3 PUFA  0.9 0.9 2.2 2.1 1.0 0.9 2.1 2.0 
n-6 PUFA  4.8 2.8 8.1 4.7 4.9 2.9 8.8 5.2 
(a): See Table 8-A-1 in the Additional information received in June 2013 124 
(b): See Table 8-B-1 in the Additional information received in June 2013 125 
                                                     
5 Information received on 22 May 2013 
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The applicant estimated the average total fat consumption of the UK population aged 19 years or 126 
older: males 80.2 g/day; females 60.8 g/day. Soybean, rapeseed and sunflower oil contribute 40 g 127 
fat/day (19.4 E %) to the total fat intake per person per day; males 46 g/day (19.4 E %); females 34.4 g 128 
fat/day (19.3 E %). That means that theoretically 57.4 % and 56.6 % of total dietary fat can be 129 
replaced by soybean MON 87705 oil in males and females, respectively, and the likely changes in 130 
total fatty acid consumption from the whole diet are calculated. The average intakes of five fatty acids 131 
(palmitic C16:0, stearic C18:0, oleic C18:1, linoleic C18:2 and α-linolenic acid C18:3) are also 132 
estimated, and the percentage changes calculated (see Table 2). Based on this consideration, the 133 
effects that a 100 % substitution of all conventional soybean, rapeseed and sunflower oils by soybean 134 
MON 87705 oil would have on the daily fatty acid intake in the total diet are predicted (see Table 2). 135 
Table 2:  Percentage of changes in fatty acid intake under the 100% substitution scenario 136 
Fatty acids 
(FA) 
Males
 
Females 
% Change in 
FA intake
(a
) 
% 
Replaceable 
vegetable 
oil in total 
diet 
Predicted 
% change 
of FA 
intake in 
total diet 
% Change 
in FA 
intake
(a)
 
% 
Replaceable 
vegetable 
oil in total 
diet 
Predicted 
% change 
of FA 
intake in 
total diet 
Palmitic acid 
C16:0 
–60.0 57.4 –34.4 –60.0 56.6 –34.4 
Stearic acid 
C18:0 
25.0 57.4 14.3 25.0 56.6 14.3 
Oleic acid 
C18:1 
93.5 57.4 53.7 91.9 56.6 52 
Linoleic acid 
C18:2 
–72.4 57.4 –41.6 –72.4 56.6 –41 
α-linolenic acid 
C18:3 
0 57.4 0 –9.1 56.6 –5.2 
(a): % Change in FA intake = (intake after substitution – intake before the substitution)/intake before the substitution; see 137 
Table 7-A-1 in the Additional information received in June 2013 138 
Predicted % change = % change of FA intake  % of replaceable vegetable oil in total diet 139 
 140 
2.2. Assessment 141 
EFSA has not set a dietary reference value (DRV) for SFAs. Several international and national 142 
authorities on nutrition recommend SFA intakes < 10 E % (EFSA NDA Panel, 2010). The baseline 143 
SFA intake in UK adults (see Table 1) is higher than 10 E %, and decreases after substitution with 144 
soybean MON 87705 oil to become nearer to the recommended level, which can be considered 145 
desirable. 146 
As expected, the intake of oleic acid, and consequently that of MUFA, considerably increases when 147 
vegetable oils are replaced with soybean MON 87705 oil. No dietary reference value has been set for 148 
MUFAs by EFSA (EFSA NDA Panel, 2010). However, the calculated increased intakes of MUFAs 149 
(18 E % vs. 12 E %) are in the range of those observed for adults in EU countries (11–21 E %). Such 150 
an increase is not expected to have an adverse impact on health. 151 
Alpha-linolenic acid (ALA) is the main dietary cis-n-3 PUFA. EFSA has proposed an adequate intake 152 
(AI) for ALA of 0.5 E % (EFSA NDA Panel, 2010). The n-3 PUFA intake, around 1 E % at baseline 153 
in men and women, would fall by about 5 % in the substitution scenario (see Table 1). The EFSA 154 
GMO Panel is of the opinion that such a decrease in the intake of n-3 PUFA is of no concern for 155 
human nutrition. 156 
Linoleic acid is the main dietary cis-n-6 PUFA. EFSA has proposed an AI for linoleic acid of 4 E % 157 
(EFSA NDA Panel, 2010). As Table 1 shows, the average and 97.5th
 
percentile intakes of n-6 PUFA 158 
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for adults would fall by around 40 % from > 4 %E to < 4 %E. The EFSA GMO Panel considers that 159 
this is unlikely to be of concern, because linoleic acid deficiency has not been observed at intakes 160 
> 1E % (EFSA NDA Panel, 2010) and because the 100 % replacement by soybean MON 87705 oil of 161 
vegetable oils in the diet is unlikely to occur. 162 
CONCLUSIONS AND RECOMMENDATIONS 163 
CONCLUSIONS 164 
The EFSA GMO Panel considers that this assessment covers all food uses for soybean MON 80775 165 
oil, and that it does not impact on human health and nutrition. 166 
The Panel notes that the suitability of oil for frying purposes depends on the behaviour of that oil when 167 
exposed continuously or repeatedly to high temperatures with regard to hydrolysis, oxidation, 168 
degradation and polymerisation. As a rule, oils containing more than 2 or 3 % of alpha-linolenic acid 169 
are regarded as not suitable for frying because it negatively influences the stability of the oil and the 170 
flavour quality of fried foods. 171 
RECOMMENDATIONS 172 
Data considered in this statement fills the data gap identified in the previous assessment (EFSA GMO 173 
Panel, 2012). Being in possession of the complete data for dietary exposure, the EFSA GMO Panel is 174 
now in position to make a recommendation on the post-market monitoring plan. 175 
A proposal for a post-market monitoring plan needs to be provided by the applicant (EFSA GMO 176 
Panel, 2011). EFSA recommends that the post-market monitoring plan focus on the collection of 177 
consumption data for the European population. 178 
For specific labelling, the applicant proposed that, for example, operators handling products 179 
containing or consisting of oil produced from soybean MON 87705 shall be required to label these 180 
products with the words “increased oleic acid oil produced from genetically modified soybean”. 181 
DOCUMENTATION PROVIDED TO EFSA 182 
1. Request from EC to EFSA, received on 7 January 2013, to complement the scientific opinion on 183 
soybean MON 87705 for commercial frying. 184 
2. Acknowledgement letter from EFSA to EC, dated 4 April 2013. 185 
3. Letter from EFSA to Monsanto, sent on 3 April 2013, requesting data. 186 
4. Reply from Monsanto to EFSA, received on 22 May, submitting data. 187 
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ABBREVIATIONS 
E %  % Energy 
MUFA  Monounsaturated fatty acid 
n-3  Omega 3 
n-6  Omega 6 
PUFA  Polyunsaturated fatty acid 
SFA  Saturated fatty acid 
